Updated list of patents available at: SEALSQ Corp (NASDAQ: LAES) ("SEALSQ" or "Company"), a company that focuses on ...

VectorY Therapeutics, a leader in vectorized antibody therapies for neurodegenerative diseases, today announced the U.K. Medicines and Healthcare Products Regulatory Agency (MHRA) and, the European ...

Detailed price information for Geovax Labs Inc (GOVX-Q) from The Globe and Mail including charting and trades.

There has been a swing towards in vivo CAR-T therapies lately, as big pharmas sign acquisition deals and new therapies hit ...

Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) is awarding US$2.6 million to AdJane to advance the development of a vaccine candidate to prevent infections caused by ...

Light does not usually surprise people. It travels, it reflects, it bends. In labs, researchers can twist it into more exotic ...

Discover why chefs keep a notebook in their jacket pocket, how it improves cooking through taste memory, reflection, and ...

In vitro data demonstratedself-complementary AAV9 (scAAV9) enabled ~30-fold higher MeCP2 protein expression compared to single-stranded AAV9 ...

If confirmed by the European Commission, REDEMPLO would be the first and only siRNA medicine authorized in the EU for both genetically confirmed and clinically diagnosed adult patients with FCS– ...

Discovery of superluminal correlations within 2D hexagonal boron nitride could advance super-resolution electron microscopy ...

Detailed price information for Geovax Labs Inc (GOVX-Q) from The Globe and Mail including charting and trades.

OPKO Health, Inc. (NASDAQ: OPK) (OPKO) reports business highlights and financial results for the three months ended March 31, 2026. Highlights from the first ...